Activating a signaling pathway with light is one of the brightest ideas to come along. Pietro de Camilli’s and Bertil Hille’s labs collaborated on a brilliant example of this illuminating technique! Optogenetic control of phosphoinositide...
Despite the importance to our health, the biology of how drugs work at the cellular level, remains largely a mystery. In a recent Public Library of Science (PLoS One) article, Montana Molecular describes new diacylglycerol sensors to help unravel some...
Imagine the possibilities! In an impressive feat of rational engineering and directed evolution, Spencer C. Alford et.al. from Bob Campbell’s lab at the University of Alberta developed ddRFP, a dimerization dependent bright new red that can be used to image...
There are advantages to starting up a biotech company in Montana. For instance, companies like Montana Molecular that receive federal SBIR Phase 1 grants are eligible for state matching funds and can be used to help cover patent applications, business development...
Excellent 3D resolution and minimal photobleaching made possible by multi photon microscopy are important advantages for fluorescence imaging in living cells. Until Misha Drobizhev et.al. tackled the issue, surprisingly little was known about the two photon absorption...
Montana Molecular Awarded 350K SBIR Phase 1 from NIH to develop fluorescent assays for cell-based drug discovery. BOZEMAN, MT. Montana Molecular was awarded an SBIR grant from the National Institute of Mental Health to develop fluorescent tools for detecting signaling...
